Findings based on a systematic literature review of studies reporting the use of ketamine, esketamine for treatment-resistant depression
Individuals with psoriasis/PsA have decreased ability to participate in social roles and activities, more depression symptoms
Most patients had co-occurring symptoms: 21.3, 19.1, and 17.4 percent had two, three, and four symptoms, respectively
Pooled prevalence estimates 25.2 and 20.5 percent for clinically elevated depression and anxiety symptoms, respectively
Fatigue, shortness of breath, and depression are the most common long COVID-19 symptoms
Increase seen in percent of teens screening positive for depression, positive suicide risk screening, and recent suicidal thoughts
Adult women with acne describe disruption to their personal and professional lives
Regular versus poor antidepressant use tied to lower risk for advanced diabetic complications, mortality in patients with depression and diabetes
Antidepressant therapy more effective than supervised physical activity at three and six months
People with two or more physical health conditions are at higher risk for developing depression, anxiety